Hospital payment cuts fund state public-option plans
States are using hospital rate cuts as a key building block to support a growing number of public-option health plans.
How a ‘mini-Optum’ saved $85 million in three years by emphasizing primary care
A Texas clinically integrated network has used a primary care physician-focused approach to lower healthcare spending by $85 million over three years.
Oct. 19-25: CMMI leader to address value-based care executives
Healthcare finance policy events for the week of Oct. 21 include an address from a CMMI executive, HFMA webinars and a deadline for comments on advance beneficiary notices.
Addressing the largest area of healthcare waste requires plans and providers to collaborate
Plans and providers should work together to systematically catalog the biggest administrative complexities responsible for unnecessary healthcare spending and develop a standardized approach to reduce or eliminate them.
Kaiser ramps up SDOH spending, but a demonstrable ROI is likely ‘years’ away
Kaiser Permanente is directing a growing share of its $2.8 billion community benefit spending to address the social determinants of health.
Oct. 13-18: Multiple national gatherings among key upcoming healthcare events
Key events include an HFMA webinar, national healthcare provider meetings and a House hearing on healthcare affordability.
HHS proposes 16 Stark, anti-kickback changes
HHS has proposed a range of rule changes to anti-fraud laws that providers say have blocked value-based payment arrangements.
Big drop in Medicaid enrollment drives 2018 increase in uninsured rate
In 2018, 1.9 million fewer people were covered by some type of health insurance, and they were most likely former Medicaid enrollees, according to new federal survey data.
Oct. 7-11: CMS listening session for hospitals among key industry events
Healthcare finance policy events for the week of Oct. 7.
What’s the outlook for prescription drug price legislation given the bipartisan efforts underway
Eye on Washington: There appears to be bipartisan support in the U.S. Senate for legislation aimed at addressing the issue of high prescription drub prices.